This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Yes, there will be changes in healthcare in the coming years but put away the thoughts that telehealth and wearable devices will revolutionize healthcare. Digital, within healthcare, is used differently by online health seekers. The post A realistic view of healthcare in 2022. Here are things I believe are more realistic.
SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. The post Dear FDA: WTF?
One agency FDA adviser, resigning from his committee post in protest, called it “probably the worst drug approval decision in recent U.S. Source: STAT News Our healthcare system can’t continue to support drugs that don’t have good clinical outcomes behind them. I, therefore, find the FDA’s decision to be puzzling.
This week, Eko Health received FDA clearance for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. The post Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart Failure in 15 Seconds appeared first on MedCity News.
After two years of pandemic fatigue, healthcare trust is at an all-time low, according to Edelman’s Trust Barometer Special Report on Trust in Healthcare. Still, the report may be too generalized for every healthcare player. While this is an excellent general overview, it does not apply to all healthcare.
Fierce Healthcare reported, “three in 4 Americans leave the doctor confused and dissatisfied for reasons that include disappointment in the level of Q&A they have with their doctor, confusion about their health, and a need to do more research, according to a survey of 1,000 U.S. So what’s the ROI?
Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Pharma companies are increasingly leveraging referral systems through peer ambassador programs, physician-to-physician education, and even digitally enabled patient communities.
In a highly regulated industry, choosing the right keywords can determine whether your ads reach healthcare professionals, patients, or caregivers effectively. Understanding how patients and healthcare professionals search for medical information is key. Using FDA-approved terminology prevents ad disapprovals and regulatory scrutiny.
So it’s very much a disruptive technology that is truly changing the paradigm of how physicians are treating prostate cancer which is really exciting. 09:24 – Jaclene Corstorphine (Guest) Yes, so with NanoKnife we are in the procedure with the physician and really highly involved in that procedure.
Food and Drug Administration (FDA) has cleared its Tasso+ lancet as a Class II medical device. The clearance allows the company to market and sell the device to more pharmaceutical companies, healthcare organizations, and academic institutions across the country, expanding access to a simple and virtually painless blood collection experience.
announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies on a wire free, single-use recorder. The FDA clearance opens the door to the world’s largest medical device market. Icentia Inc., “This approval marks a key milestone for our company.
That means that the healthcare costs in the US will keep increasing as more people get preventable health problems. billion annually in healthcare and productivity losses. There isn’t one method to get people exercising; it will take an approach for every healthcare provider to communicate the importance of exercise.
These networksspanning healthcare professionals, patients, and digital platformsare the lifeblood of modern pharma marketing. In the pharmaceutical industry, these networks often include healthcare providers, patient groups, digital channels, and key opinion leaders (KOLs). But how can we make these networks work harder and smarter?
Introduction Reaching healthcare professionals (HCPs) in the pharmaceutical industry has become increasingly challenging due to strict regulations, evolving digital landscapes, and the growing demand for personalized content. This makes PPC a cost-effective strategy for reaching niche healthcare audiences.
The current trends in digital healthcare are the use of telehealth and increased use of email to communicate with HCP’s. We are already seeing a drop in the number of people who are willing to get a COVID-19 vaccination and until trust can be re-established with the FDA and the CDC I expect that number to remain high.
The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.
Therefore, the first thing to consider when selling to physicians is that your product, device or service is safe. In addition, it needs to be approved either by the FDA or other respective authorizing body. Physicians Seek Evidence based information. When selling to physicians, yours answers should preferably be evidence based.
I’m hoping a new leader can restore the CDC and FDA’s trust and that the nationwide vaccination problem can proceed, but there are bigger issues. Drug prices remain a tiny part of our healthcare spending, yet where the facts about the excess charges, hospitals often charge patients and insurers are?
Join us as we welcome Justin Ramsaran, the dynamic VP of Digital Health at Fukuda Denshi America and CEO of R Group, who is shaping the future of healthcare with his expertise in remote patient monitoring and cardiac care innovation. ” Justin is currently a doctoral candidate at Florida Tech, working on his dissertation at NYU Stern.
Patient Pages: How Healthcare Costs Affect Insured Patients Today A new study shows an insured American with an employer-sponsored health insurance plan can expect to spend more than $320,000 (including insurance premiums and out-of-pocket costs) during his/her adult lifetime.
Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. The post ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid appeared first on.
Artificial intelligence is revolutionizing how pharma brands engage with healthcare professionals (HCPs) and patients, optimizing advertising campaigns, and improving customer experiences. As competition in the healthcare space intensifies, pharma brands that fail to integrate AI risk falling behind.
On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .
The increasing integration of platforms like LinkedIn, X (formerly Twitter), YouTube, and even TikTok has dramatically shifted how pharma brands engage with healthcare professionals (HCPs), patients, and caregivers. A physician-focused LinkedIn campaign should look and sound very different from an awareness campaign on Instagram.
Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. HCP Targeting Platforms like LinkedIn and Twitter allow brands to target physicians, pharmacists, and medical professionals based on specialty and location.
Of the eight FDA-approved weight loss drugs on the market, these two are making waves for doctors who believe they represent “a new era for weight loss medications,” and “changing options and giving hope.” They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP).
Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. I have always been passionate about improving the efficiency and equity of healthcare. B,” Massoumi says.
Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? Reaching Healthcare Professionals (HCPs) HCPs dont search the way patients do.
Jennifer Mathieu, director of government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchange (PIE) Act of 2022 and how the legislation will empower companies to share information with healthcare payers and plans during the FDA approval process. .
In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7
After surveying 2,005 nationally representative Americans, PatientPoint found that more than half are too afraid to ask their healthcare provider about their health condition or symptoms, with men even more afraid of these interactions than women (57% vs. 45%). Doctor Docs: Physicians Need Info to Treat Long COVID.
When I first read these statistics, I thought, “what a great opportunity,” but I wanted to check with some physician thought leaders. Globally, healthcare funding to private firms reached $18.09 We see new medical data almost every day, some of which the FDA says is questionable.
implantation of the HIT Reverse Hip Replacement System (Reverse HRS), under an FDA approved Investigational Device Exemption (IDE). The novel Reverse HRS is now beginning enrollment in the FDA IDE clinical trial with multiple outcome measures being evaluated.” Are you hiring?
Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis for the approximately 30 million adult patients with signs and symptoms of infection who present to US emergency departments (ED) each year. Early detection of sepsis is an invaluable capability for healthcare professionals. Are you hiring?
The 2025 Medicare Physician Fee Schedule Proposed Rule (the “2025 Proposed Rule”) issued by the Centers for Medicare and Medicaid Services (or “CMS”) on July 10, 2024 contains a number of new policy proposals with significant implications for healthcare innovators. Stakeholders should consider submitting comments on this issue.
In this article, well dive into key pharma digital marketing strategies that can help pharma brands connect with healthcare professionals (HCPs), patients, and stakeholders effectively. Paid Advertising: Targeted & Compliant Ads Paid ads on Google, LinkedIn, and healthcare-specific platforms can be a game-changer for pharma brands.
SENSORA currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system. We are making the world’s most universal medical exam objective and accurate.”
The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product. Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring.
annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today announced the appointment of accomplished healthcare technology executives Lakshmi Gudapakkam as Chief Executive Officer and clinical strategist Dr Rick Abramson as Chief Medical Officer.
The contribution will enable the programme to reach additional physicians and medical students, further expanding the initiative that aims to extend the reach of clinical trials in underserved patient populations in US communities. The Winn Award Program has so far trained 114 early-stage investigator physicians.
Digital insights consultancy Creation Healthcare gathered sentiments of HCPs about changes to X (Twitter) and transferring to different platforms, like Meta’s Threads. There are significant numbers of healthcare professionals who are neutral and appear to be reserving judgment. However, it’s not a uniform picture.
“Accurate, rapid, point of care testing can help physicians prescribe appropriate antiviral medications, minimize viral transmission in waiting rooms, and improve patient satisfaction,” said Dr. Gary Schoolnik, Chief Medical Officer at Visby Medical. The instrument-free Visby Medical device solves this problem. Are you hiring?
Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. In 2020, the FDA-approved indication was expanded to include those patients who suffer from cataplexy. Monopoly money.
Food and Drug Administration (FDA) has granted 510(k) clearance to the MedWand,” shared MedWand CEO and Co-Founder, Robert Rose. “As MedWand Mobile Clinic – Designed for physician or home visits and remote patient monitoring applications. To request a demo today visit www.medwand.com. “I I am happy to share that the U.S.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content